Cited by

• Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations.

  De Schepper J, Dab I, Derde MP, Loeb H. De Schepper J, et al. Eur J Pediatr. 1991 Apr;150(6):403-6. doi: 10.1007/BF02093718. Eur J Pediatr. 1991. PMID: 2040347
• HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis.

  Stutchfield PR, O'Halloran SM, Smith CS, Woodrow JC, Bottazzo GF, Heaf D. Stutchfield PR, et al. Arch Dis Child. 1988 Oct;63(10):1234-9. doi: 10.1136/adc.63.10.1234. Arch Dis Child. 1988. PMID: 3058046 Free PMC article.
• Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis.

  Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Holl RW, et al. Eur J Pediatr. 1995 May;154(5):356-61. Eur J Pediatr. 1995. PMID: 7641765
• Equal incidence of adult-onset diabetes among ancestors of juvenile diabetics and nondiabetics.

  Mac Donald MJ. Mac Donald MJ. Diabetologia. 1974 Dec;10(6):767-73. doi: 10.1007/BF01219539. Diabetologia. 1974. PMID: 4442668 No abstract available.
• The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. 3. Insulin responses to secretin and pancreozymin, and to oral and intravenous glucose, in patients suffering from chronic insufficiency of the exocrine pancreas.

  Raptis S, Rau RM, Schröder KE, Hartmann W, Faulhaber JD, Clodi PH, Pfeiffer EF. Raptis S, et al. Diabetologia. 1971 Jun;7(3):160-7. doi: 10.1007/BF01212548. Diabetologia. 1971. PMID: 5560917 No abstract available.